Evaluation of
Diuretic Potential of Amritarishta Prepared by
Traditional and Modern Methods in Experimental Albino Rats
Preeti Tiwari*
Head of Department of Pharmacognosy, Dr K.
N. Modi Institute of Pharmaceutical Education and
Research, Modinagar (U. P.)
*Corresponding Author E-mail: preetitiwari198311@yahoo.com
ABSTRACT:
The objective of the present study was to
evaluate the diuretic potential of Amritarishta-T and
Amritarishta-M prepared by traditional and modern
methods respectively and its marketed formulation in experimental rats using furosemide (10 mg/kg p.o.) as a
standard diuretic drug. Oral administration of Amritarishta-T,
Amritarishta-M and its marketed formulation at the
dose of 2.0 ml/kg over a period of 5 h showed a significant increase in urine
volume as compared to control group. Both types of Amritarishta
as Amritarishta-T and Amritarishta-M
prepared by traditional and modern methods respectively and its marketed
formulation showed significant increase in sodium, potassium and chloride level
in urine sample as compared to control group. The maximum diuretic effect was
produced by furosemide. Thus, both types of Amritarishta as Amritarishta-T
and Amritarishta-M and its marketed formulation
showed significant diuretic, natriuretic and kaliuretic effects.
KEYWORDS: Diuretic potential, furosemide,
Amritarishta, natriuretic
effect, kaliuretic effect.
1. INTRODUCTION:
Amritarishta is a polyherbal
hydroalcoholic Ayurvedic
preparation and is used as antioxidant and advised as a choice of remedy in
mostly all types of fevers1. The chief ingredient of Amritarishta is guduchi, dried
stem of Tinospora cordifolia.
The chemical constituents reported from stems of Tinospora cordifolia belong to different classes
such as alkaloids as tinosporin2-3, glycosides as cordifoliosides-A and cordifolioside-B4-5,
steroids as β- sitosterol6, sesquiterpenoid
as tinocordifolin7 and a large amount of phenolic
compounds as gallic acid, ellagic
acid, catechin and epicatechin8. These
compounds have many notable medicinal properties as antidiabetic9,
hepatoprotective10, antioxidant11, antimalarial12,
immunomodulatory13 and antineoplastic
properties14.
However, no study has been carried out for
the diuretic activity of Amritarishta in order to
confirm its assumed beneficial property.
Therefore, we have undertaken the present study to verify the efficacy
of all the test formulations of Amritarishta as Amritarishta-T and Amritarishta-M
prepared by traditional and modern methods respectively and its marketed
formulation as diuretic agent in albino rats.
2. MATERIALS AND METHODS:
2.1 Preparation of
Amritarishta-T:
This was prepared by the method as given in
The Ayurvedic Formulary of India, Part-I1.
All the ingredients of Amritarishta were procured
from local market, Jamnagar while jaggery was
procured from local market, Mehsana. Authentication
of all the ingredients of Amritarishta was done by
Dr. G. D. Bagchi, Scientist, Department of Taxonomy
and Pharmacognosy, Central Institute of Medicinal and Aromatic Plants, Lucknow. Prepared herbarium has been deposited in the
Central Institute of Medicinal and Aromatic Plants, Lucknow
for future reference. Identification of all the individual plant material was
done as per The Ayurvedic Pharmacopoeia of India.
Quantity of ingredients taken for the preparation of batch size 3.072 l of Amritarishta has been calculated according to the formula
as given in The Ayurvedic Formulary of India, Part-I,
2000.
According to this method, coarsely powdered
stems of guduchi (Tinospora cordifolia) with prescribed ingredients
as Aegle marmelos
(stem bark), Oroxylum indicum (roots),
Gmelina arborea (stem
bark), Stereospermum suaveolns
(stem bark), Premna integrifolia
(stem bark), Hedysarum gangeticum (entire
plant), whole plant of Paederia foetida,
entire plant of Solanum indicum,
entire plant of Solanum xanthocarpum
and Tribulus terrestris
were placed in polished vessel of brass along with prescribed quantity of water
(12.288l) and allowed to steep. After 12 h of steeping, this material was
warmed at medium flame until the water for decoction reduced to one fourth of
the prescribed quantity(3.072 l) , then the heating was stopped and it was
filtered in cleaned vessel and after that jaggery was
added and mixed properly. Then, prakshepa dravyas as svet jiraka, raktapuspaka, saptaparni, sunthi, marica, pippali, nagakesara, mustaka, katuka, ativisa and indravaruni in fine powdered form were added and this sweet
filtered material was placed for fermentation in incubator for fifteen days at
33±1°C. After 15 days completion of fermentation was confirmed by standard
tests15. The fermented preparation was filtered with cotton cloth
and kept in clean covered vessel for further next seven days. Then, when the
fine suspended particles settled down, it is strained again and poured in amber
colored glass bottles previously rinsed with ethyl alcohol, packed and properly
labelled.
2.2 Preparation of
Amritarishta-M:
Method of preparation of Amritarishta-M was same as followed for Amritarishta-T
only in addition to jaggery, yeast was also added for
inducing fermentation16.
2.3 Animals:
Adult wistar
albino rats, weighing between 200-220g of either sex were acclimatized to
normal environmental conditions in the animal house for one week. The animals were
housed in standard polypropylene cages and maintained under controlled room
temperature (22șC±2șC) and humidity (55±5%) with 12:12 hour light and dark
cycle. All the animals were given a standard chow diet (Hindustan Lever
Limited) and water ad libitum.
The guidelines of the Committee for the Purpose of Control and Supervision of Experimentals on Animals (CPCSEA) of the Government of
India were followed and prior permission was granted from the Institutional
Animals Ethics Committee (CPCSEA No. 07/09).
2.4. Experimental
Procedure:
The method of Lipschitz
et al., (1943) was employed for the assessment of diuretic activity. Twenty
four hours before testing the animals were transferred to metabolic cages17.Then
only water was made accessible ad libitum without food.
All the animals were randomly divided into
the five groups with six animals in each group as follows:
Group I Control group received normal
saline as vehicle (25 ml/kg, p.o.)
Group II Animals received furosemide (10 mg/kg, p.o.)
Group III Animals received Amritarishta-T (2 ml/kg, p.o.)
Group IV Animals received Amritarishta-M (2 ml/kg, p.o.)
Group V Animals received marketed Amritarishta (2 ml/kg, p.o.)
The second group received same volume of
normal saline (25 ml) in which furosemide (10 mg/kg bw) was dissolved. The animals of Group III, IV and V
received Amritarishta-T, Amritarishta-M
and marketed Amritarishta at the dose of 2 ml/kg bw orally, after diluting to all of them up to 25 ml with
normal saline to maintain the fluid intake same in all the cases. Immediately
after dosing the rats were placed in metabolic cages and kept at room
temperature of 25 șC±0.5 șC for 5 h. During this period, no food and water was
made available to them. At the end of 5 h the animals were taken out of the cages
and the total volume of urine excreted by each group was noted. Urine samples
were analysed thereafter for Na+ and K+
concentration by flame photometer while chloride (Cl-)
was determined by using standard kit containing chloride reagent from span
diagnostics, Surat, India.
2.5. Statistical
analysis:
The results have been expressed as mean ±
SEM. Statistical analysis of data among the various groups was performed by
using one way analysis of variance (ANOVA) followed by the Tukeys
test using Graph Pad Prism software of Statistics. Significance value (P<0.05) was considered statistically
significant.
3. RESULTS:
Diuretic effect:
Total urine
output:
Both types of Amritarishta
as Amritarishta-T and Amritarishta-M
were prepared by traditional and modern methods respectively showed significant
(P<0.001) increase in urine
volume, as compared to control group. The diuresis
was almost equal to that produced by furosemide (Fig.1).
Fig. 1. Effect of Amritarishta-T, M and marketed Amritarishta
on urine volume
All values are expressed as mean ± SEM (n =
6); b P<0.001 as compared to
control
Urinary
electrolyte concentration:
Urinary sodium: All the test formulations of Amritarishta as Amritarishta-T, Amritarishta-M and its marketed formulation were found to
produce significant (P<0.001)
increase in natriuresis but the maximum natriuresis was produced by furosemide
(Fig.2).
Urinary potassium:
Both types of Amritarishta
as Amritarishta-T and Amritarishta-M
have been found to produce significant (P<0.001)
increase in the excretion of potassium in urine as compared to the control
group. Furosemide also significantly increased the
excretion of potassium. Thus, all the test formulations of Amritarishta
showed significant kaliuretic effect (Fig.2).
Urinary chloride:
All the test formulations of Amritarishta as Amritarishta-T, Amritarishta-M and its marketed formulation showed
significant (P<0.001) increase in
the excretion of chloride in urine as compared to control. Furosemide
also showed significant increase in the excretion of chloride in urine (Fig.2).
Fig. 2. Effect of Amritarishta-T, M and marketed Amritarishta
on urinary electrolyte concentration
All values are expressed as mean ± SEM (n =
6); b P<0.001 as compared to control
4. DISCUSSION:
This study shows that both types of Amritarishta as Amritarishta-T
and Amritarishta-M prepared by traditional and modern
methods respectively and its marketed formulation produced striking increase in
total urine output over a period of 5 h. All these test formulations of Amritarishta also showed significant (P<0.001) increase in the excretion of sodium, potassium and
chloride in urine as compared to control group. Therefore, both types of Amritarishta as Amritarishta-T
and Amritarishta-M have been shown to possess
significant diuretic, natriuretic and kaliuretic effects which may be one of the basis of their
therapeutic application in various ailments, such as nephritis, burning micturation etc. and different oedematous
diseases. Their diuretic effects have been shown to be more or less equal to
that produced by furosemide.
Preliminary phytochemical
studies have confirmed the presence of phenolics,
particularly hydrolysable tannins and flavonoids and
other nonphenolic constituents as steroidal saponins in all the test formulations of Amritarishta as Amritarishta-T, Amritarishta-M and its marketed formulation, promoting the
hypothesis that these type of polar compounds may also be responsible for the
diuretic effects. It is known that this type of compounds increase renal
circulation, and thus the rate of glomerular
filtration which promotes increased urine formation18-20. Thus,
presence of self generated alcohol helps in the faster absorption of biologically
active compounds as tannins, flavonoids and steroidal
saponins which by their chemical nature are
antioxidants, might contribute to the prevention of cardiac diseases as
hypertension by acting as diuretics21
5. REFERENCES:
1) The Ayurvedic
Formulary of India, Part-I. 2000, 1st edition, The Controller of
Publications, Delhi, 6.
2) Kumar S, Verma
NS, Pande D and Srivastava
PS. In vitro regeneration and
screening of berberinein Tinospora cordifolia. Journal of Medicinal and
Aromatic Plant Science 2000;22:61.
3) Biset NG and Nwaiwu
J. Quaternary alkaloids of Tinospora species.
Planta Medica
1983;48:275-9.
4) Maurya R, Wazir
V, Tyagi A and Kapil RS. Cordifoliosides A and B, two new phenylpropene
disaccharides from Tinospora cordifolia
possessing immunostimulant activity. Natural Product
Letter 1996;8:7-10.
5) Gangan VD, Pradhan
P, Sipahimalani AT and Banerji
A. Cordifoliosides A, B, C: Norditerpene
furan glycosides from Tinospora cordifolia.
Phytochemistry 1994; 37:781-6.
6) Dixit SN and Khosa
RL. Chemical investigation of Tinospora cordifolia. Indian Journal of Applied Chemistry 1971;
34:46-7.
7) Maurya R and Handa
SS. Tinocordifolin, a sesquiterpene
from Tinospora cirdifolia.
Phytochemistry 1998; 49:1343-6.
8) Kidwai AR, Salooja
KC, Sharma VN, Siddiqui S. Chemical examination of Tinospora cordifolia.
Journal of Science and Indian Research 1949; 8:115-8.
9) Stanely M, Prince P and Menon VP. Antioxidant action of Tinospora cordifolia root extract in alloxan diabetic rats.Phytotherapy
Research 2001; 15:213-8.
10) Mehrotra R, Katiyar
CK and Gupta AP. Hepatoprotective compositions and
composition for treatment of conditions related to hepatitis-B and E infection.
US Patent 749296. 2000.
11) Prince PS and Menon VP. Antioxidant activity of Tinospora cordifolia roots in experimental
diabetes. Journal of Ethnopharmacology 1999;
65:277-81.
12) Ikram M, Khattak
SG and Gilani SN. Antipyretic studieson
some indigenous Pakistani medicinal plants. Journal of Ethnopharmacology
1987; 19:185-92.
13) Manjrekar PN, Jolly CI and Narayanan S.
Comparative studies of immunomodulatory activity of Tinospora cordifolia
and Tinospora sinensis. Fitoterapia 2000;71:254-7.
14) Jagetia GC, Nayak
V and Vidyasagar MS. Evaluation of the antineoplastic activity of guduchi
(Tinospora cordifolia)
in cultured HeLa cells. Cancer Letter 1998;
127:71-82.
15) Mishra S. Bhaisazya
Kalpana Vigyan. Varanasi,
India: Chaukambha Surbharati
Prakashan; 2005.p. 253-254.
16) Alam M, Radhamani
S, Ali U and Purushottam KK. Microbiological
Screening of Dhataki flowers. Journal of Research in Ayurveda and Siddha 1984;
2(4):371-375.
17) Lipschitz WL, Hadidian
Z, Kerpcsar A. Bioassay of Diuretics. Journal of
Pharmacology and Experimental Therapeutics 1943; 79: 97-110.
18) Afzal M, Khan NA, Ghufran
A, Iqbal A, Inamuddin M.
Diuretic and nephroprotective effect of Jawarish Zarooni Sada- a polyherbal Unani formulation. Journal of Ethnopharmacology
2004;91:219-223.
19) Loew D, Heimsoth
V, Erwin K, Schilcher H. 1991. Diureticos:
Quimica, Farmacologiay Therapeutica incluida Fitoterapia, Barcelona, Salvat Editores S.A.:270.
20) Das PK, Goswami
S, Chinniah A. Woodfordia fruticosa: Traditional uses and recent
findings. Journal of Ethnopharmacology 2007;
110:189-199.
21) Hollman PCH, Katan
MB. Dietary Flavonoids: Intake, Health effects and
bioavailability. Food and Chemical Toxicology 1999; 37:937-942
Received
on 26.11.2013 Modified
on 13.01.2014
Accepted
on 17.02.2014 ©A&V Publications All right reserved
Res.
J. Pharmacology & Pdynamics. 6(2): April- June
2014; Page 71-74